Clik here to view.
Varian Medical shares rise after Street-beating Q3
Varian Medical (NYSE:VAR) saw shares rise 5% after releasing 3rd quarter earnings that handily beat the Street’s expectations. The Palo Alto, Calif.-based company reported profits of $98.9 million, or...
View ArticleClik here to view.
Derma Sciences acquires BioD for $21.3m
Derma Sciences (NSDQ:DSCI) said today it is buying regenerative medicine developer BioD for $21.3 million up front, with the possibility of an additional $56.5 million. The deal between Princeton,...
View ArticleClik here to view.
Smith & Nephew touts 1st-use of Navio robotic-assisted knee system
A New York hospital is the 1st to use Smith & Nephew (NYSE:SNN) new robotics-assisted total knee replacement procedure following its recent 510(k) clearance from the FDA. The surgery took place at...
View ArticleClik here to view.
Critics of weight-loss device urge U.S. regulator to reverse approval
(Reuters) – Lotta Bosnyak takes extra time to chew the blueberries in her yogurt. Otherwise, she said, the device she credits with saving her life will not work. The tube Bosnyak is referring to has...
View ArticleClik here to view.
Abiomed posts solid Q1, lifts full year outlook
Abiomed (NSDQ:ABMD) lifted its revenue guidance for the year after posting a Street-beating 1st quarter today. The Danvers, Mass.-based company reported profits of $12.9 million, or 29¢ per share, on...
View ArticleClik here to view.
Merit Medical Q2 beats on EPS, misses on rev
Merit Medical (NSDQ:MMSI) today released its 2nd quarter earnings, beating the Street on earnings per share but falling short on revenue. The South Jordan, Utah-based company reported profits of $7.3...
View ArticleClik here to view.
Auris Surgical Robotics closes $80m Hansen Medical buy
Hansen Medical (NSDQ:HNSN) said today it completed its $80 million merger with Auris Surgical Robotics, which won approval from shareholders last week. Through the merger agreement, Auris paid $4 per...
View ArticleClik here to view.
Penumbra touts stent retriever study data
Penumbra (NYSE:PEN) said a 198-patient trial of its next-generation stroke-treatment device along with another company product showed promise, meeting primary endpoints. Results were positive enough...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for July 28, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Orthofix wins Japanese regulatory win for Phoenix spinal fixation system
Orthofix (NSDQ:OFIX) said today it won regulatory approval from the Japanese Ministry of Health, Labor and Wellfare for its Phoenix minimally invasive spinal fixation system. The Phoenix system allows...
View ArticleClik here to view.
Heartware Q2 sees losses shrink, beats the street
HeartWare International (NSDQ:HTWR) today released 2nd quarter earnings that beat the Street alongside shrinking losses as the company is slated to be picked up Medtronic (NYSE:MDT) in a $1.1 billion...
View ArticleClik here to view.
Medtronic touts 1st enrollment in Reality PAD study
Medtronic (NYSE:MDT) said yesterday it enrolled the 1st patients in the VIVA-sponsored Reality study assessing outcomes of peripheral artery disease patients treated with directional atherectomy and...
View ArticleClik here to view.
Women’s health focused NVision Medical raises $12m in Series B
Stealthy NVision Medical has raised $12 million in Series B financing, with funds slated to support product development, clinical studies and regulatory submissions to for its micro-catheter...
View ArticleClik here to view.
From discovery to delivery: Moving academic innovations to the market
“Wouldn’t it be great if we could come up with a noninvasive diagnostic assay to detect pancreatic cancer at an earlier, more treatable stage?” asked Lori Aro of Myriad Genetics. Her company has been...
View ArticleClik here to view.
Align Tech releases street-beating Q2, announces deal with SmileDirectClub
Align Technology (NSDQ:ALGN) yesterday released its 2nd quarter earnings, handily beating the street on revenue and earnings per share and announcing a new agreement with SmileDirectClub. The reported...
View ArticleClik here to view.
SPR Therapeutics wins FDA nod for peripheral nerve stim pain relief device
Pain management company SPR Therapeutics yesterday said it won FDA 510(k) clearance for its Sprint peripheral nerve stimulation system designed to provide chronic pain relief. The Cleveland, Ohio-based...
View ArticleClik here to view.
CareFusion recalls select AVEA ventilators over electrical issues
The FDA yesterday released information on a select recall of CareFusion AVEA Ventilators due to electrical issues which could cause unexpected shutdowns. The federal watchdog labeled the recall as a...
View ArticleClik here to view.
Tactile Systems reduces IPO to $46m
Leg compression device developer Tactile Systems Technology reduced its initial public offering to $46 million. Those estimates are down approximately 24% from the $60 million it said it hoped to bring...
View ArticleClik here to view.
BioVentus delays $150m IPO
Orthobiologics maker Bioventus postponed its initial public offering which was slated to raise up to $150 million for the company, according to Renaissance Capital. The company plans to float 8.8...
View ArticleClik here to view.
ResMed shares lift on solid Q4 posting
ResMed (NYSE:RMD) yesterday released 4th quarter earnings that beat the Street and sent shares up, despite missing on fiscal year 2016 expectations. For the quarter, ResMed reported profits of $83.1...
View Article
